Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China

Cancer Epidemiology

Volumn 36, Issue 4, 2012, Pages 369-374

  Wang, Qi ^a   Zhang, Tao ^a   Ye, Lihong ^a   Wang, Wenhui ^b   Zhang, Xiaodong ^a  

^a NANKAI UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Hepatitis B virus X gene; Hepatocellular carcinoma; Mutation

Indexed keywords

HEPATITIS B VIRUS X PROTEIN;

ADULT; AGED; AMINO ACID ANALYSIS; ARTICLE; CANCER PATIENT; CHINA; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; AGED; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; TRANS-ACTIVATORS; YOUNG ADULT;

EID: 84863444680     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.11.006     Document Type: Article

References (28)

1. Kao J.H., Chen D.S. Global control of hepatitis B virus infection. Lancet Infect Dis 2002, 2:395-403.
2. Zhang X.D., Zhang W., Ye L.H. Pathogenesis of hepatitis B virus infection. Future Virol 2006, 1:637-647.
3. Tanaka Y., Kanai F., Kawakami T., Tateishi K., Ijichi H., Kawabe T., et al. Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis. Biochem Biophys Res Commun 2004, 318:461-469.
4. Kwon S.Y., Park Y.K., Ahn S.H., Cho E.S., Choe W.H., Lee C.H., et al. Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients. J Virol 2010, 84:4494-4503.
5. Tenney D.J., Rose R.E., Baldick C.J., Pokornowski K.A., Eggers B.J., Fang J., et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy. Hepatology 2009, 49:1503-1514.
6. Enomoto M., Tamori A., Kohmoto M.T., Morikawa H., Habu D., Sakaguchi H., et al. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences. J Med Virol 2007, 79:1664-1670.
7. Cha C.K., Kwon H.C., Cheong J.Y., Cho S.W., Hong S.P., Kim S.O., et al. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B. J Med Virol 2009, 81:417-424.
8. Takahashi K., Akahane Y., Hino K., Ohta Y., Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 1998, 143:2313-2326.
9. Baptista M., Kramvis A., Kew M.C. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 1999, 29:946-953.
10. Venard V., Corsaro D., Kajzer C., Bronowicki J.P., Le Faou A. Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma. J Med Virol 2000, 62:177-184.
11. Chen W.N., Oon C.J., Leong A.L., Koh S., Teng S.W. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance. Biochem Biophys Res Commun 2000, 276:885-892.
12. León B., Taylor L., Vargas M., Luftig R.B., Albertazzi F., Herrero L., et al. HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers. Virol J 2005, 2:60.
13. Lee J.H., Han K.H., Lee J.M., Park J.H., Kim H.S. Impact of hepatitis B virus (HBV) X gene mutations on hepatocellular carcinoma development in chronic HBV infection. Clin Vaccine Immunol 2011, 18:914-921.
14. Iyer S., Groopman J.D. Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival. Mol Carcinog 2011, 50:972-980.
15. Chen G.G., Li M.Y., Ho R.L., Chak E.C., Lau W.Y., Lai P.B. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. J Clin Virol 2005, 34:7-12.
16. Tu H., Bonura C., Giannini C., Mouly H., Soussan P., Kew M., et al. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 2001, 61:7803-7810.
17. Zhang H., Shan C.L., Li N., Zhang X., Zhang X.Z., Xu F.Q., et al. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation. Acta Pharmacol Sin 2008, 29:473-480.
18. Liu X., Zhang S., Lin J., Zhang S., Feitelson M.A., Gao H., et al. Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells. Biochem Biophys Res Commun 2008, 373:643-647.
19. Wang Q., Zhang W., Liu Q., Zhang X., Lv N., Ye L.H., et al. A mutant of hepatitis B virus X Protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. Neoplasia 2010, 12:103-115.
20. Park S.G., Lee S.M., Jung G. Antisense oligodeoxynucleotides targeted against molecular chaperonin Hsp60 block human hepatitis B virus replication. J Biol Chem 2003, 278:39851-39857.
21. Liu X.H., Lin J., Cao X.Z., Zheng J.M., Chen Y., Zhu M.H. Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells. Zhonghua Yi Xue Za Zhi 2005, 85:825-830.
22. Yeh C.T., Shen C.H., Tai D.I., Chu C.M., Liaw Y.F. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene 2000, 19:5213-5220.
23. Hsia C.C., Nakashima Y., Tabor E. Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 1997, 241:726-729.
24. Xu R., Zhang X., Zhang W., Fang Y., Zheng S., Yu X. Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology 2007, 46:1810-1820.
25. Kim C.M., Koike K., Saito I., Miyamura T., Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991, 351:317-320.
26. Koike K., Moriya H., Yotsuyanagi H., Iino S., Kurokawa K. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 1994, 94:44-49.
27. Diao J., Garces R., Richardson C.D. X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 2001, 12:189-205.
28. Madden C.R., Slagle B.L. Stimulation of cellular proliferation by hepatitis B virus X protein. Dis Markers 2001, 17:153-157.